Ontario’s Premier Life Science Competition Celebrates 10 Years of Health Innovation
Applications are now open for this year’s cohort of innovative startups Hamilton – October 12,
Applications are now open for this year’s cohort of innovative startups Hamilton – October 12,
Making a smart site selection could drive the commercialization of your intellectual property. Here are three examples that are helping to make Hamilton, Ontario, the next leader in life sciences research and commercialization.
Eye3 has gained significant traction including securing financing, developing product concepts and prototypes and filing for patents.
Understanding the common commercialization hurdles mentioned above is one thing, but having the funding and the time to navigate through them is another.
ORIGINAL ARTICLE, Ritika Dubey, The Hamilton Spectator, July 26, 2022 Q and A: Dr. Harald Stover
Medtech startup Cosm Medical has secured $4.7 million CAD to create custom medical devices for women suffering from pelvic floor disorders.
Hamilton, ON — On March 23, 2022, nearly 200 people from the region’s thriving life
Press Release: HyIvy Health Hyivy Health’s innovative pelvic health rehabilitation system looks to provide a
LSO is a member-funded, not-for-profit organization advancing Ontario’s life sciences through advocacy and policy work,
Discover how Synmedix is combating antibiotic resistance with support from the SOPHIE program and Synapse Life Science Competition.
As a CAMEDA recipient, Verv Technologies will be collaborating with InertiaPD to advance key aspects of its technology platform.
The Molecules and Masterpieces event showcased the SOPHIE program’s role as a catalyst for life science partnerships, commercialization and innovation.
Discover how Synmedix is combating antibiotic resistance with support from the SOPHIE program and Synapse Life Science Competition.
Femtech startup Cosm Medical is changing women’s pelvic health with a medical device that combines software, AI and 3D printing.
Discover how the SOPHIE program guided Epineuron Technologies’ efforts towards a pain-free future for people with peripheral nerve damage.
The Molecules and Masterpieces event showcased the SOPHIE program’s role as a catalyst for life science partnerships, commercialization and innovation.
With support from the Government of Canada, Innovation Factory launches the Canadian MedTechAlliance (CAMEDA) program.
Innovation Factory announces an MOU with HaloHealth to deliver a collaborative medical assessment & physician advisory service to SOPHIE companies.
Southern Ontario Pharmaceutical & Health Innovation Ecosystem (SOPHIE) Program brings together Innovation Factory’s commercialization services with the Synapse Life Science Consortium’s strategic network to leverage access to Hamilton’s unique life sciences capabilities and research expertise.